FDA Expects Closing Gap On NDI Notifications To Open Window Wider On Supplements Sold In US

FDA regulatory framework for VMS product manufacturing and marketing provides little pre-market transparency into what’s available in US, but it’s clear from post-market monitoring by the Office of Dietary Supplement Programs that compliance with the NDI notification requirement is lax.

• Source: Shutterstock

The US Food and Drug Administration expects to thin the herd of dietary supplement marketers flouting its new dietary ingredient notification rule with a temporary extension of a compliance deadline before swinging its lassos over the remaining strays.

The FDA’s regulatory framework for vitamin, mineral and supplement product manufacturing and marketing provides little pre-market transparency into what’s available...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation